RBLX EBITDA
-$719.86MTTM · USD
Period ending:
RBLX FY EBITDAUSD
$0.00-$910.95M
2018-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
RBLX ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| -802,175,000 | |
| -670,250,000 | |
| -910,950,000 | |
| -761,864,000 | |
| -421,397,000 | |
| -220,539,000 | |
| -43,441,000 | |
| -75,611,000 |
Compare ebitda
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) ebitda
- HSBC Holdings, plc. Common Stock (HSBC) ebitda
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) ebitda
- Novartis AG Common Stock (NVS) ebitda
- Royal Bank Of Canada Common Stock (RY) ebitda
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) ebitda
- SAP SE ADS (SAP) ebitda
- AstraZeneca PLC Ordinary Shares (AZN) ebitda
All RBLX financial metrics · RBLX stock overview · How to interpret financial metrics
